SerImmune
Serimmune has become part of Infinity Bio, Inc., a global leader in innovative antibody reactome services. This partnership combines Serimmune’s short epitope profiling and discovery platform with Infinity Bio’s advanced technologies, accelerating progress in immunology research and translational science. The company continues to provide science, innovation, and support with expanded capabilities and resources.
Industries
Nr. of Employees
small (1-50)
Patents
Products
COVID-RUO Profiling
Multiplex profiling service for 14 SARS-CoV-2 proteins with single amino acid resolution across the entire proteome to power discoveries in longitudinal and long-haul COVID studies.
Biomarker Discovery Services
A discovery service using the SERA platform combining large biological libraries, NGS, and custom bioinformatics to unlock the circulating antibody repertoire and achieve hypothesis-free serology.
SERA Platform
Serum Epitope Repertoire Analysis (SERA) is an antibody repertoire analysis platform combining universal chemistry with proprietary informatics to assess antibody repertoires, identify epitopes and motifs, and address research and clinical needs.
Immune Profiling Services
Comprehensive profiling services utilizing the SERA platform to broadly profile antibody repertoires and identify antigens and epitopes associated with many diseases.
Serum Epitope Repertoire Analysis
Proprietary technology platform used to investigate and profile personal immune responses and map antibody specificities to target epitopes.
COVID-RUO Profiling
Multiplex profiling service for 14 SARS-CoV-2 proteins with single amino acid resolution across the entire proteome to power discoveries in longitudinal and long-haul COVID studies.
Biomarker Discovery Services
A discovery service using the SERA platform combining large biological libraries, NGS, and custom bioinformatics to unlock the circulating antibody repertoire and achieve hypothesis-free serology.
SERA Platform
Serum Epitope Repertoire Analysis (SERA) is an antibody repertoire analysis platform combining universal chemistry with proprietary informatics to assess antibody repertoires, identify epitopes and motifs, and address research and clinical needs.
Immune Profiling Services
Comprehensive profiling services utilizing the SERA platform to broadly profile antibody repertoires and identify antigens and epitopes associated with many diseases.
Serum Epitope Repertoire Analysis
Proprietary technology platform used to investigate and profile personal immune responses and map antibody specificities to target epitopes.
Services
Service to map antibody reactivity against short linear epitopes for discovery and research applications.
Analytical service to generate antibody reactivity maps across antigen repertoires using peptide- and protein-based reagents.
Service to map antibody reactivity against short linear epitopes for discovery and research applications.
Analytical service to generate antibody reactivity maps across antigen repertoires using peptide- and protein-based reagents.
Expertise Areas
- Epitope mapping and discovery
- Antibody reactome analysis
- Peptide and protein reagent development
- Serological profiling
Key Technologies
- Short-epitope profiling
- Rational peptide design
- Full-length protein assays
- Antibody reactome mapping